Oncogenes in Human Leukemias

References

• DeFeo-Joncs D, Tatchell K, Robinson L C., et al. Mammalian and yeast ras gene products; biological function in their heterologous systems. Science 1985; 228: 179–184
   PubMed Web of Science ®Google Scholar
• Wyke I. Principles of viral leukemogenesis. Sem Hematol 1986; 23: 189–200
   PubMed Web of Science ®Google Scholar
• Croce C M., Noweil P C. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1–7
   PubMed Web of Science ®Google Scholar
• Croce C M. Chromosome translocations and human cancer. Cancer Res 1986; 46: 6019–6023
   PubMed Web of Science ®Google Scholar
• Gale R P., Canaani E. The molecular biology of chronic myelogenous leukemia. Br J Haematol 1985; 60: 395–408
   PubMed Web of Science ®Google Scholar
• Silver R T., Gale R P. Chronic myeloid leukemia. Am J Med 1986; 80: 1137–1148
   PubMed Web of Science ®Google Scholar
• Bartram C R. bcr rearrangement without juxtaposition of c-abl in chronic myelogenous leukemia. J Exp Med 1985; 162: 2175–2179
   PubMed Web of Science ®Google Scholar
• Ganesan T S., Rassool F, Gou A-P, et al. Rearrangement of the bcr gene in Philadelphia chromosome negative chronic myelogenous leukemia. Blood 1986; 68: 957–960
   PubMed Web of Science ®Google Scholar
• Dreazen O, Gorodetsky L, et al. Molecular biology of Ph1 positive acute lymphoblastic leukemia in childhood. Blood 1986; 68(suppl. 1)198a
   Google Scholar
• De Klein A, Hagenmeijer A, Bartram C R., et al. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood 1986; 68: 1369–1375
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Yunis J, Onorato-Showe L, et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leuke-mias with the t(11;14) chromosome translocation. Science 1984; 224: 1403–1406
   PubMed Web of Science ®Google Scholar
• Erikson J, Finan J, Tsujimoto Y, et al. The chromosome 14 breakpoint in neoplastic B cells with the t(11; 14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci (USA) 1984; 81: 4144–4148
   PubMed Web of Science ®Google Scholar
• Pegoraro L, Palumbo A, Erikson J, et al. A (14; 18) and (8; 14) translocation in a cell line derived from an acute B cell leukemia. Proc Natl Acad Sci (USA) 1984; 81: 7166–7170
   PubMed Web of Science ®Google Scholar
• Geary M L., Smith S S., Sklar J. Cloning and structural analysis of cDNA for bcl-2 and a hybrid bcl-2/Immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19–28
   PubMed Web of Science ®Google Scholar
• Croce C M., Isobe M, Palumbo A, et al. Gene for a chain of human T cell receptor: location on chromosome 14 region involved in T cell neoplasms. Science 1985; 227: 1044–1047
   PubMed Web of Science ®Google Scholar
• Diaz M O., Le Beau M M., et al. Interferon and c-etsl genes in the translocation (9; 11) (p22;q23) in human acute monocytic leukemia. Science 1985; 231: 265–267
   Web of Science ®Google Scholar
• Sacchi N, Watson D K., van Kessel H MG, et al. Hu-etsl and Hu-ets2 genes are transposed in acute leukemia with (4; 11) and (8;21) translocation. Science 1986; 231: 379–382
   PubMed Web of Science ®Google Scholar
• Diaz M O., Le Beau M M., Rowley J D., et al. The role of the c-mos gene in the 8;21 translocation in human acute myelobiastic leukemia. Science 1985; 229: 767–769
   PubMed Web of Science ®Google Scholar
• Nienhuis A W., Bunn H F., Turner P, et al. Expression of the human c-fms protc-oncogene in hematopoietic cells and its deletion in the 5 q- syndrome. Cell 1985; 42: 421–428
   PubMed Web of Science ®Google Scholar
• Srivastava A, Nahreni P, Heerema N, et al. Ki-ras oncogene over-expression in a human preleukemia syndrome involving chromosome 5. Exp Hematol 1986; 14: 432
   Web of Science ®Google Scholar
• Westbrook C A., Le Beau M M., Diaz M O., et al. Chromosomal localization and characterization of c-abl in the t(6;9) of acute nonlym-phocytic leukemia. Proc Natal Acad Sci (USA) 1985; 82: 8742–8746
   PubMed Web of Science ®Google Scholar
• Le Beau M M., Westbrook C A., et al. c-src conserved in the chromosomal deletion (20 q) observed in myeloid disorders. Proc Natl Acad Sci (USA) 1985; 82: 6692–6696
   PubMed Web of Science ®Google Scholar
• Diaz M O., Le Beau M M., et al. Trisomy 8 in human haematologic neoplasia and the c-myc and c-mos oncogenes. Leukemia Res 1985; 9: 1437–1442
   PubMed Web of Science ®Google Scholar
• Dayton A L., Sekton J, Laws G, et al. A human erb-A oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia. Proc Natl Acad Sci (USA) 1984; 81: 4495–4499
   PubMed Web of Science ®Google Scholar
• Le Beau M M., Westbrook C A., Diaz M O., et al. Translocation of the p53 gene in t(15;17) in acute promyelocytic leukemia. Nature 1985; 316: 826–828
   PubMed Web of Science ®Google Scholar
• Isobe M, Enamel B S., Givoli D, et al. Localization of gene for human p53 tumor antigen to band 17p 13. Nature 1986; 320: 83–85
   Google Scholar
• Copeland N G., Cooper G M. Transfection by exogenous and endogenous murine retrovirus DNAs. Cell 1979; 16: 347–353
   PubMed Web of Science ®Google Scholar
• Bos J L., Verlaand de Vries M, Jansen A M., et al. Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucl Acids Res 1984; 12: 9155–9163
   PubMed Web of Science ®Google Scholar
• Bos J L., Toksoz D, Marshall C J., . Activated ras oncogenes in acute leukemia. Minimal Residual Disease in Acute Leukemia 1986, A Hagenbeek, B Lowenberg, et al. Nijhoff, Dordrecht 1986; 43–50
   Google Scholar
• Murray M J., Cunningham J M., Parad L F., et al. A ras oncogene coexisting with alterated myc genes in hematopoietic tumors. Cell 1983; 33: 749–752
   PubMed Web of Science ®Google Scholar
• Janssen W G., Steenvoorden A CM, Collard J G., et al. Oncogene activation in human myeloid leukemia. Cancer Res 1985; 45: 3262–3267
   PubMed Web of Science ®Google Scholar
• Bos J L., Toksoz D, Marshall C J., et al. Amino acid substitution at codon 13 of the N-ras oncogene in human acute myelogenous leukemia. Nature 1985; 45: 3262–3267
   Google Scholar
• Gambke C, Signer E, Moroni C. Activation of N-ras gene in bone marrow cells from a patients with acute myelobiastic leukemia. Nature 1984; 307: 476–478
   PubMed Web of Science ®Google Scholar
• Bos J L., Verlaan-de Vries M, van der Erb J, et al. Mutation in N-ras predominate in acute myelogenous leukemia. Blood 1987; 69: 1237–1241
   PubMed Web of Science ®Google Scholar
• Hirai H, Tanaka S, Azuma M, et al. Transforming genes in human leukemia cells. Blood 1985; 66: 1371–1378
   PubMed Web of Science ®Google Scholar
• Eva A, Tronick S R., Goll R A., et al. Transforming genes of human hemopoietic tumors: frequent deletion of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci (USA) 1983; 80: 4926–4930
   PubMed Web of Science ®Google Scholar
• Needleman S W., Kraus M H., Srivastava S K., et al. High frequency of N-ras activation in acute myelogenous leukemia. Blood 1986; 67: 753–757
   PubMed Web of Science ®Google Scholar
• Souyri M, Fleissner E. Identification by transfection of transforming sequences in DNA of human T cell leukemias. Proc Natl Acad Sci (USA) 1983; 80: 6670–6679
   Google Scholar
• Lane M A., Sainten A, Cooper G M. Stage specific transforming genes of human and mouse B and T lymphocyte neoplasms. Cell 1982; 28: 873–880
   PubMed Web of Science ®Google Scholar
• Diamond A, Cooper G M., Ritz J, et al. Identification and molecular cloning of the human Blym transforming gene activated in Burkitt lymphomas. Nature 1983; 305: 112–116
   PubMed Web of Science ®Google Scholar
• Ozanne B, Wheeler T, Zack J, et al. Transforming gene of a human leukemia cell is unrelated to the expressed tumor virus related gene of the cell. Nature 1982; 299: 744–747
   PubMed Web of Science ®Google Scholar
• Collins S, Groudine M. Amplification of endogenous myc related DNA sequences in a human myeloid leukemia cell line. Nature 1982; 298: 679–681
   PubMed Web of Science ®Google Scholar
• Dalla Favera R, Wong-Staal F, Gallo R C. Oncogene amplification in promyelocytic leukemia cell line HL-69 and primary leukemia cells of the same patient. Nature 1982; 299: 61–63
   PubMed Web of Science ®Google Scholar
• Mc Carthy D M., Rassool F V., Goldman J M., et al. Genomic alteration involving the c-myc proto-oncogenes locus during the evolution of a case of chronic granulocytic leukemia. Lancet 1984; ii: 1362–1364
   Google Scholar
• Alitalo K, Saksela K, Winqvist R, et al. Acute myelogenous leukemia with c-myc amplification and double minute chromosome. Lancet 1985; ii: 1035–1038
   Google Scholar
• Collins S J., Groudine M T. Rearrangements and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K562. Proc Natl Acad Sci (USA) 1983; 80: 4813–4817
   PubMed Web of Science ®Google Scholar
• Selden J R., Emanuel B S., Wang E, et al. Amplified C, and c-abl genes are the same marker chromosome in K562 leukemia cells. Proc Natl Acad Sci (USA) 1983; 80: 7289–7292
   PubMed Web of Science ®Google Scholar
• Pelicci P G., Lanfrancone L, Brathwarte M D., et al. Amplification of the c-myb oncogene in a case of acute myelogenous leukemia. Science 1984; 224: 1117–1121
   PubMed Web of Science ®Google Scholar
• Yokota J, Tsumetsugu-Yokota Y, Battiflora H, et al. Alterations of myc, myb and rasHa proto-oncogenes in cancer are frequent and shows clinical correlation. Science 1986; 231: 261–265
   PubMed Web of Science ®Google Scholar
• Westin E H., Gallo R C., Arya S K., et al. Differential expression of the amv gene in human hematopoietic cells. Proc Natal Acad Sci (USA) 1982; 79: 2194–2198
   PubMed Web of Science ®Google Scholar
• Westin E H., Wong-Staal F, Gelmann E P., et al. Expression of cellular homologues of retroviral one genes in human hematopoietic cells. Proc Natal Acad Sci (USA) 1982; 79: 2490–2494
   PubMed Web of Science ®Google Scholar
• Blick M, Westin E, Gutterman J, et al. Oncogene expression in human leukemia. Blood 1984; 64: 1234–1239
   PubMed Web of Science ®Google Scholar
• Slamon D J., De Kernon J B., et al. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• Ferrari S, Torelli U, Selleri L, et al. Study of the levels of expression of two oncogenes, c-myc ans c-myb in acute and chronic leukemias of both lymphoid and myeloid lineage. Leukemia Res 1985; 9: 833–842
   PubMed Web of Science ®Google Scholar
• Slamon D, Boone T C., Murdock D C., et al. Studies of the human c-myb gene and its prediction in human acute leukemias. Science 1986; 223: 347–351
   Google Scholar
• de Kretser T, Adams K., Savin J, et al. Elevated level of abl-related transcripts in leukemic lymphoblasts. Med Pediatr Oncol 1985; 13: 133
   PubMedGoogle Scholar
• Romero P, Blick M, Talpaz M, et al. C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies. Blood 1986; 67: 839–841
   PubMed Web of Science ®Google Scholar
• Calabretta B, Venturelli D, Kaczmarek L, et al. Altered expression of G,-specific genes in human malignant myeloid cells. Proc Natl Acad Sci (USA) 1986; 83: 1495–1498
   PubMed Web of Science ®Google Scholar
• Preisler H D., Kinniburgh A J., Wei-Dong G, et al. Expression of the proto-oncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission, Submitted
   Google Scholar
• Mavilio F, Testa U, Sposi N M., et al. Selective expression of c-fos oncogene in acute myelomonocytic and monocytic leukemias: a molecular marker of terminal differentiation. Blood 1987; 69: 160–164
   PubMed Web of Science ®Google Scholar
• Canaani E, Gale R P., Steiner-Salz D, et al. Altered transcription of an oncogene in chronic myeloid leukemia. Lancet 1984; i: 593–595
   Google Scholar
• Heisterkamp N, Stam K, Groffen J, et al. Structural organization of the bcr gene and its role in the Ph' translocation. Nature 1985; 315: 758–761
   PubMed Web of Science ®Google Scholar
• Leibowitz D, Cubbon R, Bank A. Increased expression of a novel c-abl related RNA in K562 cells. Blood 1985; 65: 526–529
   PubMed Web of Science ®Google Scholar
• Sthiveiman E, Lifshitz B, Gale R P., et al. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr/abl fused gent. Cell 1986; 47: 227–284
   Google Scholar
• Birnie G D., Bums J H., Widemann L M., et al. A new approach to the classification of human leukemias: measurement of the relative abundance of a specific RNA sequence by means of molecular hybridization. Lancet 1983; i: 197–200
   Google Scholar
• Birnie G D., Burns J H., et al. Lineage-specific and differentiation stage specific gene expression in normal and leukemic human myeloid cells. J Royal Soc Med 1984; 77: 289–294
   PubMed Web of Science ®Google Scholar
• Shiosaka T, Saunders G F. Differential expression of selected genes in human leukemia leukocytes. Proc Natl Acad Sci (USA) 1982; 79: 4668–4671
   PubMed Web of Science ®Google Scholar
• Evinger Hodges M J., Biesser J, Dickie K A., et al. Proto-oncogene expression in human normal hematopoietic cells. Exp Hematol 1986; 14: 432
   Web of Science ®Google Scholar
• Reed J C., Alpers J D., et al. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natal Acad Sci (USA) 1986; 83: 3982–3986
   PubMed Web of Science ®Google Scholar
• Gowda S D., Koler R D., Bagby G C. Regulation of c-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells. J Clin Invest 1986; 77: 271–278
   PubMed Web of Science ®Google Scholar
• Duprey S P., Boettinger D. Developmental regulation of c-myb in normal myeloid progenitor cells. Proc Natl Acad Sci (USA) 1985; 82: 6937–6941
   PubMed Web of Science ®Google Scholar
• Popenoe D, Schaefer-Rego K, Mears J G., et al. c-abl oncogene expression during erythroleukemia cell differentiation. Blood 1985; 66(suppl 1)243a
   PubMedGoogle Scholar
• Craig R W., Block A. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (Ml-1) cells induced with 12–0-tetradecanoylphorbol-13-acetate. Cancer Res 1984; 44: 442–446
   PubMed Web of Science ®Google Scholar
• Muller R, Curran T, et al. Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature 1986; 314: 546–548
   Web of Science ®Google Scholar
• Mitchell R L., Zokas L, et al. Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell 1985; 40: 209–217
   PubMed Web of Science ®Google Scholar
• Konopka I B., Watanabe S M., Wine O. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tryosin kinase activity. Cell 1984; 37: 1035
   PubMed Web of Science ®Google Scholar
• Clarck S S., McLaughin J, Crist W M., et al. Unique form of the abl protein kinase distinguish Ph positive CML from Ph positive ALL. Science 1987; 235: 85–88
   PubMed Web of Science ®Google Scholar
• Kloetzer W, Kurzrock R, Smith L, et al. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology 1985; 140: 230–238
   PubMed Web of Science ®Google Scholar
• Witte O N., Dasgupta A, Baltimore D. Abelson murine leukemia virus protein is phospholirad in vitro to phsophotyrosine. Nature 1980; 283: 826–831
   PubMed Web of Science ®Google Scholar
• Collett M S., Erikson R L. Protein kinase activity associated to the avian sarcoma virus src gene product. Proc Natl Acad Sci (USA) 1978; 75: 2021–2124
   PubMed Web of Science ®Google Scholar
• Feldman R A., Gabrilove J L., Tarn J P., et al. Specific expression of the human cellular fps/fes encoded protein NCP92 in normal and leukemic cells. Proc Natl Acad Sci (USA) 1985; 82: 2379–2383
   PubMed Web of Science ®Google Scholar
• Hayward W S., Neel B G., Astrin S M. Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 1981; 290: 475–480
   PubMed Web of Science ®Google Scholar
• Lane M A., Neary D, Cooper G M. Activation of a cellular transforming gene in tumours induced by Abelson murine leukaemia virus. Nature 1982; 300: 659–661
   PubMed Web of Science ®Google Scholar
• Feramisco J R., Clark R, Wong G, et al. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature 1985; 314: 639–642
   PubMed Web of Science ®Google Scholar
• Michalevicz R, Francis G E., et al. The role of platelet-derived growth factor on human pluripotent progenitor (CFU-GEMM) growth in vitro. Leukemia Res 1985; 9: 399–405
   PubMed Web of Science ®Google Scholar
• Armelin H A., Armelin M CS, Kelly K, et al. Functional role for c-myc in mitogenic response to platelet-derivated growth factor. Nature 1984; 310: 655–660
   PubMed Web of Science ®Google Scholar
• Kelly K, Cochran B H., et al. Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet derived growth factor. Cell 1985; 35: 603–610
   Web of Science ®Google Scholar
• Yamamoto T, Dcawa S, Akiama T, et al. Similarity of protein encoded by human c-erb-B-2 gene to epidermal growth factor receptor. Nature 1986; 319: 230–234
   PubMed Web of Science ®Google Scholar
• Sherr I C., Rottemier C W., Sacca R, et al. The c-rms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF1. Cell 1985; 41: 665–676
   PubMed Web of Science ®Google Scholar
• Rapp U R., Cleveland J L., Brightman K, et al. Abrogation of IL2 and IL3 dependence by recombinant murine retrovirus expressing v-myc oncogenes. Nature 1985; 317: 434–438
   PubMed Web of Science ®Google Scholar